Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Frontiers in Immunology
|
November 17, 2022
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Tobias Zeller, Sebastian Lutz, Ira A Münnich, et al.
Clinical & Translational Immunology
|
March 11, 2020
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
Felix S Lichtenegger, Frauke M Schnorfeil, Maurine Rothe, et al.
Cancer Immunology Research
|
September 19, 2022
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma
Carlotta Welters, María Fernanda Lammoglia Cobo, Christian Alexander Stein, et al.
Nature Cancer
|
December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Andrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Frontiers in Immunology
|
November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
Armin Gerbitz, Regina Gary, Michael Aigner, et al.
Nature Communications
|
September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection
Elham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
The European Respiratory Journal
|
June 29, 2023
Antiviral CD8<sup>+</sup> T-cell immune responses are impaired by cigarette smoke and in COPD
Jie Chen, Xinyuan Wang, Adrian Schmalen, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Frontiers in Immunology
|
November 17, 2022
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Tobias Zeller, Sebastian Lutz, Ira A Münnich, et al.
Clinical & Translational Immunology
|
March 11, 2020
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
Felix S Lichtenegger, Frauke M Schnorfeil, Maurine Rothe, et al.
Cancer Immunology Research
|
September 19, 2022
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma
Carlotta Welters, María Fernanda Lammoglia Cobo, Christian Alexander Stein, et al.
Nature Cancer
|
December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Andrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Frontiers in Immunology
|
November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
Armin Gerbitz, Regina Gary, Michael Aigner, et al.
Nature Communications
|
September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection
Elham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
The European Respiratory Journal
|
June 29, 2023
Antiviral CD8<sup>+</sup> T-cell immune responses are impaired by cigarette smoke and in COPD
Jie Chen, Xinyuan Wang, Adrian Schmalen, et al.
Page
of 6